Trials that use: Interim analysis / alpha spending
New to this method? Read the tutorial →
11,819 results
- SISIndependent statistical analysis of A Study in Adolescent and Adult Female Participants to Evaluate Clinical Symptom Improvement and the Safety of Gepotidacin During Treatment of Uncomplicated Urinary Tract Infections (Acute Cystitis): primary…
- SIS Versus Office Hysteroscopy for Uterine Cavity Evaluation Prior to IVF: Complete Statistical AnalysisIndependent statistical analysis of SIS Versus Office Hysteroscopy for Uterine Cavity Evaluation Prior to IVF: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- SISCAIndependent statistical analysis of Comparison of Two Treatment Strategies in Patients With an Acute Coronary Syndrome Without ST Elevation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- SISTA-PIndependent statistical analysis of Sistas Informing Sistas on Topics About AIDS and Prevention (SISTA-P): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06307028).
- SISTErIndependent statistical analysis of Comparison of Surgical Procedures to Reduce Urinary Stress Incontinence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00064662).
- SISTERSIndependent statistical analysis of SISTERS: Spasticity In Stroke Study - Randomized Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01032239).
- Sitagliptin Added-on to Insulin Study (0431-051): Complete Statistical AnalysisIndependent statistical analysis of Sitagliptin Added-on to Insulin Study (0431-051): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00395343).
- Sitagliptin Comparative Study in Patients With Type 2 Diabetes (0431-049): Complete Statistical AnalysisIndependent statistical analysis of Sitagliptin Comparative Study in Patients With Type 2 Diabetes (0431-049): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00449930).
- Sitagliptin Dose Comparison Study in Patients With Type 2 Diabetes (MK-0431-077)(COMPLETED): Complete Statistical AnalysisIndependent statistical analysis of Sitagliptin Dose Comparison Study in Patients With Type 2 Diabetes (MK-0431-077)(COMPLETED): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Sitagliptin/Metformin (JANUMET) Re-examination Study (0431A-182): Complete Statistical AnalysisIndependent statistical analysis of Sitagliptin/Metformin (JANUMET) Re-examination Study (0431A-182): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01065766).
- Sitaxsentan Efficacy And Safety Trial With A Randomized Prospective Assessment Of Adding Sildenafil (SR-PAAS): Complete Statistical AnalysisIndependent statistical analysis of Sitaxsentan Efficacy And Safety Trial With A Randomized Prospective Assessment Of Adding Sildenafil (SR-PAAS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- site markingIndependent statistical analysis of Visibility of Site Marking for Surgical Time Out With Two Different Skin Preparation Solutions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Sitravatinib in Advanced Liposarcoma and Other Soft Tissue Sarcomas: Complete Statistical AnalysisIndependent statistical analysis of Sitravatinib in Advanced Liposarcoma and Other Soft Tissue Sarcomas: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02978859).
- Six-month Study to Compare the Effects of Volume- and Pressure-Guided Adjustments on Weight Loss and Satiety: Complete Statistical AnalysisIndependent statistical analysis of Six-month Study to Compare the Effects of Volume- and Pressure-Guided Adjustments on Weight Loss and Satiety: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- SJ4 Post Approval Study in Implantable Cardioverter-Defibrillator and Cardiac Resynchronization Therapy Defibrillator Patients: Complete Statistical AnalysisIndependent statistical analysis of SJ4 Post Approval Study in Implantable Cardioverter-Defibrillator and Cardiac Resynchronization Therapy Defibrillator Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Skills Training to Enhance Vocational Outcomes in Veterans With Serious Mental Illness: Complete Statistical AnalysisIndependent statistical analysis of Skills Training to Enhance Vocational Outcomes in Veterans With Serious Mental Illness: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Skin Surface and Intradermal Temperature Responses to Heat Stress: Complete Statistical AnalysisIndependent statistical analysis of Skin Surface and Intradermal Temperature Responses to Heat Stress: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06593067).
- SKYGGNIndependent statistical analysis of OCS-01 in Treating Inflammation and Pain in Post-cataract Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04130802).
- Skylight 2Independent statistical analysis of A Study to Find Out if Fezolinetant Helps Reduce Moderate to Severe Hot Flashes in Women Going Through Menopause - 2: primary endpoint results, effect estimate with confidence…
- SLD3Independent statistical analysis of Assessment of Hyperphosphorylated Tau PET Binding in Primary Progressive Aphasia and Frontotemporal Dementia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- SLEIndependent statistical analysis of A Prospective Study of Cyclophosphamide in Systemic Lupus Erythematosus Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01689350).
- Sleep and Circadian Treatments for Shift Workers: Complete Statistical AnalysisIndependent statistical analysis of Sleep and Circadian Treatments for Shift Workers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03813654).
- Sleep Device Testing to Promote Sleep in Infants: Complete Statistical AnalysisIndependent statistical analysis of Sleep Device Testing to Promote Sleep in Infants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05078112).
- Sleep Innovations for Preschoolers With Arthritis (SIPA): Developing and Pilot Testing of a Self-Management Intervention: Complete Statistical AnalysisIndependent statistical analysis of Sleep Innovations for Preschoolers With Arthritis (SIPA): Developing and Pilot Testing of a Self-Management Intervention: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Sleep Schedules Modifications in Sleep Apnea Patients Treated by nCPAP: Complete Statistical AnalysisIndependent statistical analysis of Sleep Schedules Modifications in Sleep Apnea Patients Treated by nCPAP: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01355419).
- SleepTightIndependent statistical analysis of Sleep Apnea in TIA/Stroke: Reducing Cardiovascular Risk With Positive Airway Pressure: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- SLSIndependent statistical analysis of Scleroderma Lung Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00004563).
- SLSIIIIndependent statistical analysis of Scleroderma Lung Study III - Combining Pirfenidone With Mycophenolate: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03221257).
- SLVP023Independent statistical analysis of Pilot Study in Young Adults to Examine the Kinetics of Changes in the B-cell Repertoire Following TIV Immunization: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- SMA-TBIndependent statistical analysis of Adjunctive Acetylsalicylic Acid and Ibuprofen for Tuberculosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04575519).
- SMAHRTIndependent statistical analysis of Self-Management Addressing Heart Disease Risk Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00499096).
- Small Bowel Capsule Endoscopy Findings in Patients Receiving Cellcept®: Complete Statistical AnalysisIndependent statistical analysis of Small Bowel Capsule Endoscopy Findings in Patients Receiving Cellcept®: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00652834).
- SMART 2Independent statistical analysis of SMART 2.0: Social Mobile Approaches to Reducing weighT in Young Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- SMART GIVESIndependent statistical analysis of Multi-Center Study of New Medications to Treat Vaginal Infections: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02308007).
- SMART GIVESIndependent statistical analysis of Multi-Center Study of New Medications to Treat Vaginal Infections: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02308046).
- SMART ONEIndependent statistical analysis of Stereotactic MRI-guided Adaptive Radiation Therapy (SMART) in One Fraction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04939246).
- SMART Study: A Study of Re-treatment With MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on Anti-TNF Alfa Therapy: Complete Statistical AnalysisIndependent statistical analysis of SMART Study: A Study of Re-treatment With MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on Anti-TNF Alfa Therapy: primary endpoint results, effect estimate with confidence…
- Smart Telehealth Exercise Intervention to Reduce COPD Readmissions: Complete Statistical AnalysisIndependent statistical analysis of Smart Telehealth Exercise Intervention to Reduce COPD Readmissions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03089853).
- SMART Trial: Intrapersonal and Interpersonal Stigma Reduction: Complete Statistical AnalysisIndependent statistical analysis of SMART Trial: Intrapersonal and Interpersonal Stigma Reduction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04693416).
- Smart-TR01Independent statistical analysis of Smartphone Based Smoking Cessation Intervention: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03740490).
- Smartband Mindfulness Study: Complete Statistical AnalysisIndependent statistical analysis of Smartband Mindfulness Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03995225).
- SMaRTBloodIndependent statistical analysis of SMaRT Blood: Single-unit Versus Multiple-unit Packed Red Blood Cell Transfusion in Non-acute Postpartum Anemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- SMARTERIndependent statistical analysis of Symbicort Maintenance and Reliever Therapy - Experience in Real Life Setting in Malaysia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- SMARTERIndependent statistical analysis of Social Media and Risk Reduction Teaching-Enhanced Reach: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04387552).
- SmartfIREIndependent statistical analysis of A Study For Treatment Of Paroxysmal Atrial Fibrillation (PAF) With The THERMOCOOL SMARTTOUCH SF Catheter and TRUPULSE Generator: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- SMARTPLUS-106Independent statistical analysis of Study to Assess Safety and Efficacy of the Second Mitochondrial-derived Activator of Caspases (SMAC) Mimetic Debio 1143: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Smell, Voice and Nasal Swabs as Markers for Neuro-degenerative Disorders: Complete Statistical AnalysisIndependent statistical analysis of Smell, Voice and Nasal Swabs as Markers for Neuro-degenerative Disorders: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03299062).
- Smith-Lemli-Opitz Syndrome and Cholic Acid: Complete Statistical AnalysisIndependent statistical analysis of Smith-Lemli-Opitz Syndrome and Cholic Acid: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03720990).
- Smoke-free Home Intervention in Permanent Supportive Housing: Complete Statistical AnalysisIndependent statistical analysis of Smoke-free Home Intervention in Permanent Supportive Housing: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04855357).
- Smoking Cessation E-Visit: Complete Statistical AnalysisIndependent statistical analysis of Smoking Cessation E-Visit: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04316260).